Impact of ICCAN on Cancer Treatment Completion and Quality of Life
ConditionCancer Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21-80
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).
Eligibility criteria
Qualifiers
fluent in English, Spanish, or Mandarin
between the ages of 21-80 years old
cancer patients currently receiving chemotherapy (started within the past month) and/or radiation therapy (started within the past week), or
scheduled to begin chemotherapy and/or radiation therapy within the next 2 months (excluding surgery only patients)
Disqualifiers
Diagnosed with Stage IV disease
Presence of untreated psychiatric disturbance (i.e. acute psychiatric symptoms which require individual treatment) and/or cognitive impairment disorder (e.g., delirium or dementia) verified by medical record sufficient to preclude completion of the assessment measures, interview or informed consent
Has another family member already enrolled in ICCAN (as determined by patient report)
Presence of untreated psychiatric disturbance (e.g., acute psychiatric symptoms which require individual treatment) and/or cognitive impairment disorder (e.g., delirium or dementia) sufficient to preclude completion of the assessment measures, interview or informed consent
Trial design
Treatments tested in this trial
- The Integrated Cancer Care Access Network (ICCAN)
- Usual and Customary Group (U&C)
Treatment groups
347 Participants
are divided into 3 treatment groupsSponsors and collaborators
Memorial Sloan Kettering Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator
The City College of New York
Collaborator
Ralph Lauren Center for Cancer Care and Prevention
Collaborator
Lincoln Medical and Mental Health Center
Collaborator
Lutheran Medical Center
Collaborator
Source ClinicalTrials.gov